27659183|t|Performance and safety of collagenated xenogeneic bone block for lateral alveolar ridge augmentation and staged implant placement. A monocenter, prospective single-arm clinical study
27659183|a|To assess the clinical safety and performance of collagenated xenogeneic bone block (CXBB) for lateral alveolar ridge augmentation and two-stage implant placement. In ten patients exhibiting a single - tooth gap, the surgical procedure included the preparation of mucoperiosteal flaps, a rigid fixation of CXBB (Geistlich Bio-Graft(®)) using an osteosynthesis screw, and contour augmentation. After 24 weeks of submerged healing, the primary endpoint was defined as the final ridge width sufficient to place an adequately dimensioned titanium implant at the respective sites. Secondary outcomes included, for example, the gain in ridge width (mm). Clinical parameters (e.g., bleeding on probing - BOP, probing depth - PD, mucosal recession - MR) were assessed immediately after the cementation of the crown and at the final visit. At 24 weeks, implant placement could be achieved in 8 of 10 patients exhibiting a mean gain in ridge width (mean ± SD) of 3.88 ± 1.75 mm. Histological analysis has pointed to a homogeneous osseous organization of CXBB. The changes of mean BOP, PD, and MR values at the final visit amounted to 16.62 ± 32.02%, 0.04 ± 0.21 mm, and -0.04 ± 0.12 mm, respectively. CXBB may be successfully used to support lateral alveolar ridge augmentation and two-stage implant placement.
27659183	0	11	Performance	T052	C1882330
27659183	16	22	safety	T080	C0086139
27659183	26	60	collagenated xenogeneic bone block	T122	C0181075
27659183	65	100	lateral alveolar ridge augmentation	T061	C0002387
27659183	105	129	staged implant placement	T061	C0021107
27659183	133	182	monocenter, prospective single-arm clinical study	T062	C2826346
27659183	186	192	assess	T058	C0184514
27659183	197	212	clinical safety	T080	C2826199
27659183	217	228	performance	T052	C1882330
27659183	232	266	collagenated xenogeneic bone block	T122	C0181075
27659183	268	272	CXBB	T122	C0181075
27659183	278	313	lateral alveolar ridge augmentation	T061	C0002387
27659183	318	327	two-stage	T079	C0574055
27659183	328	345	implant placement	T061	C0021107
27659183	354	362	patients	T101	C0030705
27659183	363	373	exhibiting	T078	C0449450
27659183	376	382	single	T081	C0205171
27659183	385	390	tooth	T023	C0040426
27659183	391	394	gap	T082	C3887622
27659183	400	418	surgical procedure	T061	C0543467
27659183	419	427	included	T052	C2700399
27659183	432	443	preparation	T052	C1521827
27659183	447	467	mucoperiosteal flaps	T017	C1881914
27659183	471	485	rigid fixation	T061	C0185023
27659183	489	493	CXBB	T122	C0181075
27659183	495	517	Geistlich Bio-Graft(®)	T170	C0282574
27659183	528	548	osteosynthesis screw	T074	C0005975
27659183	554	561	contour	T082	C0876954
27659183	562	574	augmentation	T061	C1293122
27659183	594	611	submerged healing	T040	C0043240
27659183	617	633	primary endpoint	T130	C2986535
27659183	653	658	final	T079	C3853528
27659183	659	664	ridge	T029	C0447361
27659183	665	670	width	T081	C0487742
27659183	671	681	sufficient	T080	C0205410
27659183	694	704	adequately	T080	C0205410
27659183	705	716	dimensioned	T081	C0439534
27659183	717	733	titanium implant	T061	C2165380
27659183	752	757	sites	T082	C0205145
27659183	759	777	Secondary outcomes	T080	C3274440
27659183	778	786	included	T052	C2700399
27659183	805	809	gain	T081	C1517378
27659183	813	818	ridge	T029	C0447361
27659183	819	824	width	T081	C0487742
27659183	831	850	Clinical parameters	T062	C2347800
27659183	858	877	bleeding on probing	T033	C2698524
27659183	880	883	BOP	T033	C2698524
27659183	885	898	probing depth	T081	C1317646
27659183	901	903	PD	T081	C1317646
27659183	905	922	mucosal recession	T190	C0333047
27659183	925	927	MR	T190	C0333047
27659183	934	942	assessed	T052	C1516048
27659183	965	989	cementation of the crown	T061	C0458893
27659183	1001	1012	final visit	T061	C0204309
27659183	1027	1044	implant placement	T061	C0021107
27659183	1054	1062	achieved	T052	C1706701
27659183	1074	1082	patients	T101	C0030705
27659183	1083	1093	exhibiting	T078	C0449450
27659183	1096	1100	mean	T081	C0444504
27659183	1101	1105	gain	T081	C1517378
27659183	1109	1114	ridge	T029	C0447361
27659183	1115	1120	width	T081	C0487742
27659183	1122	1126	mean	T081	C0444504
27659183	1129	1131	SD	T081	C0871420
27659183	1152	1164	Histological	T080	C0002809
27659183	1165	1173	analysis	T062	C0936012
27659183	1191	1202	homogeneous	T082	C0439713
27659183	1203	1210	osseous	T023	C0262950
27659183	1211	1223	organization	T169	C1300196
27659183	1227	1231	CXBB	T122	C0181075
27659183	1237	1244	changes	T169	C0392747
27659183	1248	1252	mean	T081	C0444504
27659183	1253	1256	BOP	T033	C2698524
27659183	1258	1260	PD	T081	C1317646
27659183	1266	1268	MR	T190	C0333047
27659183	1269	1275	values	T081	C1522609
27659183	1283	1294	final visit	T061	C0204309
27659183	1295	1303	amounted	T081	C1265611
27659183	1374	1378	CXBB	T122	C0181075
27659183	1386	1398	successfully	T080	C0679864
27659183	1407	1414	support	T077	C1521721
27659183	1415	1450	lateral alveolar ridge augmentation	T061	C0002387
27659183	1455	1464	two-stage	T079	C0574055
27659183	1465	1482	implant placement	T061	C0021107